A.   Relief of pain

B.   Increased serum albumin levels

C.   Increased urine specific gravity

D.   Decreased adrenocorticotropic hormone levels

A.   Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

B.   Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

C.   Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

D.   Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

A.   Choriomammotropin

B.   Somatostatin

C.   Somatropin

D.   Somatolactin

A.   Cosyntropin

B.   Oxytocin

C.   Vasopressin

D.   Octreotide

A.   Polydipsia

B.   Hypopituitary dwarfism

C.   Polyuria

D.   Acromegaly

A.   Somatropin

B.   Luteinizing hormone

C.   Vasopressin

D.   Desmopressin

A.   Complete blood count result

B.   Creatinine clearance test

C.   Blood glucose level

D.   Uric acid level

A.   Carbamazepine

B.   Ciprofloxacin

C.   Demeclocycline

D.   Cyclosporine

A.   Cosyntropin

B.   Oxytocin

C.   Thyroid hormone

D.   Octreotide

A.   Polydipsia

B.   Dehydration

C.   Polyuria

D.   Headache

A.   Somatropin

B.   Octreotide

C.   Desmopressin

D.   Cosyntropin

A.   Vasopressin

B.   Desmopressin

C.   Somatropin

D.   Octreotide

A.   Enhances the effects of desmopressin

B.   Reduces the effects of desmopressin

C.   Causes prolongation of QT interval

D.   Produces an additive effect

A.   Hypotension

B.   Edema

C.   Scar formation

D.   Inflammation

A.   Dyspnea, Constipation, Hypercalciuria

B.   Malaise, Dyspnea,

C.   Arthralgia, Hypercalciuria, Constipation

D.   Constipation, Malaise, Hypercalciuria

A.   Liver enzyme levels, Blood glucose levels, Renal function studies

B.   Liver enzyme levels, Renal function studies, Weight

C.   Weight, Blood pressure, Blood glucose levels

D.   Renal function studies, Liver enzyme levels, Blood pressure

A.   Norepinephrine

B.   Acetaminophen

C.   Thioridazine

D.   Carbamazepine

A.   Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

B.   Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C.   Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

D.   Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A.   Decreases fluid retention

B.   Reduces fat levels

C.   Reduces weight loss

D.   Decreases growth

A.   Diabetes insipidus, Seizure, Type I von Willebrand

B.   Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

C.   Asthma, Diabetes insipidus, Type I von Willebrand

D.   Seizure, Asthma, Cardiovascular disease

A.   Glucocorticoids

B.   Ciprofloxacin

C.   Fludrocortisone

D.   Cyclosporine

A.   Hyperglycemia

B.   Hypokalemia

C.   Hyponatremia

D.   Orthostatic hypotension

A.   Hypoglycemia

B.   Edema

C.   Heartburn

D.   Seizures

A.   Desmopressin and carbamazepine

B.   Vasopressin and demeclocycline

C.   Somatropin and glucocorticoids

D.   Vasopressin and carbamazepine

A.   A 17-year-old who is 5 feet tall

B.   A 10-year-old of short stature who has severe asthma

C.   An 8-year-old with a pituitary tumor

D.   A 7-year-old diagnosed with growth hormone deficiency

A.   Human immunodeficiency virus (HIV) infection

B.   Acute bronchitis with laryngitis

C.   Bilateral metastatic breast cancer

D.   Cachexia and closed growth plates

A.   Loss of consciousness

B.   Abundant, diluted urine

C.   Oozing blood

D.   Watery diarrhea

A.   "Inhale the drug preparation by spraying into the nostrils."

B.   "Apply the drug preparation topically to the nasal membranes."

C.   "Shake the drug preparation thoroughly before use."

D.   "Dilute the drug preparation before administration."

A.   Hypertension

B.   Hypothyroidism

C.   Hyperglycemia

D.   Hypercalciuria

A.   Replacing the cap on the pump after the procedure

B.   Pressing the pump once to spray a 10-mcg dose

C.   Pressing down on the pump two times to prime it

D.   Priming the nasal pump once a week

A.   Motor skills, Visual acuity, Skin turgor

B.   Weight, Skin turgor, Visual acuity

C.   Skin turgor, Height, Visual acuity

D.   Height, Weight, Motor skills

A.   "Is there any change in the color of your urine?" "Is there any change in the color of your sputum?"

B.   "Do you have excessive bleeding due to minor injuries?" "Is there any change in the color of your urine?"

C.   "Do you feel very thirsty lately?" "How many times do you urinate in a day?"

D.   "Is there any change in the color of your sputum?" "Do you have excessive bleeding due to minor injuries?"

A.   Inhaling the medication into the airway

B.   Administering half the dose in each nostril

C.   Priming the pump each week

D.   Storing the pump at room temperature

A.   A higher dose of medication is required for treatment.

B.   The medication is not effective for this condition.

C.   The patient needs to adjust fluid intake.

D.   The patient is stable and needs reassurance.

A.   Fatigue, Headache

B.   Diarrhea, Flushing

C.   Joint pain, Fatigue

D.   Headache, Joint pain

A.   Patient A: esophageal varices; type 1 diabetes

B.   Patient D: VIP; severe diarrhea and flushing; renal impairment

C.   Patient B: carcinoid tumor; taking ciprofloxacin

D.   Patient C: VIP; life-threatening hypotension; diarrhea and flushing

A.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Replace the cap on the bottle. 5. Give half a spray in each nostril. 6. Monitor the level of drug left in the pump.

B.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

C.   1. Clear the nasal passages. 2. Give half a spray in each nostril. 3. Place the spray nozzle in the nostril. 4. Prime the pump by pressing down four times. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

D.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Monitor the level of drug left in the pump. 6. Replace the cap on the bottle.

A.   Small-bowel fistula and having an acute asthma attack

B.   Esophageal varices and a history of type 2 diabetes

C.   Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

D.   Acromegaly and a serum creatinine level of 5.0 mg/dL

A.   Make a note of the fluid intake.

B.   Measure the patient’s urine output regularly.

C.   Watch the IV site closely for infiltration.

D.   Assess for signs of dehydration.

A.   Elevated blood pressure, Weight gain

B.   Weight gain, Edema of the extremities

C.   Increased urination, Thirst

D.   Edema of the extremities, Elevated blood pressure

A.   Assess the patient for headaches

B.   Monitor for signs of infiltration

C.   Inquire about abdominal discomfort

D.   Notice increase in body temperature

A.   Obtain baseline weight and height measurements

B.   Review the frequency with the health care provider

C.   Review current laboratory values for blood glucose

D.   Calculate the dosage with the pharmacist or another nurse

A.   Reports episodic muscle pain during the past year.

B.   Radiology report identifies no fracture with closed growth plates.

C.   Growth percentile has increased from the previous annual physical.

D.   Previous somatropin injection site tender to touch.

A.   Blood glucose

B.   Renal panel

C.   Liver enzymes

D.   Electrocardiogram (ECG)

A.   Somatropin intramuscular

B.   Vasopressin nasal spray

C.   Desmopressin intravenously

D.   Octreotide subcutaneous

A.   Nausea, Blood glucose elevation, Headache, Low blood pressure

B.   Nausea, Blood glucose elevation, Headache, Low urine output

C.   Headache, Low urine output, Low blood pressure, Nausea

D.   Low blood pressure, Blood glucose elevation, Headache, Low urine output

A.   Limping

B.   Bleeding gums

C.   Abdominal cramps

D.   Excessive thirst

A.   Co-administering carbamazepine

B.   Obtaining liver and renal function tests

C.   Administering the vasopressin intravenously

D.   Monitoring the patient in an intensive care unit

A.   Monitor fluid status.

B.   Encourage vigorous exercise.

C.   Evaluate the patient for limping.

D.   Monitor blood glucose levels closely.

A.   "Keep the bottle in warm water before administration."

B.   "Shake the medication before administration."

C.   "Do not administer the drug to the patient."

D.   "Heat the medicine before administration."

A.   Abdominal stress

B.   Vertigo

C.   Bleeding gums

D.   Drowsiness

A.   Somatropin

B.   Vasopressin

C.   Desmopressin

D.   Cosyntropin

A.   "If it is almost time for your next dose, take a double dose of the drug at that time."

B.   "You can take the dose immediately when you remember it."

C.   "Skip the missed dose and resume your usual dosage schedule."

D.   "You should consult your primary health care provider immediately."

A.   Octreotide

B.   Desmopressin

C.   Somatropin

D.   Vasopressin

A.   Corticotropin

B.   Desmopressin

C.   Somatropin

D.   Octreotide